CAMK2N2: A Potential Drug Target and Biomarker for Cancer and Other Diseases

Target Name: CAMK2N2

NCBI ID: G94032

CAMK2N2

CAMK2N2: A Potential Drug Target and Biomarker for Cancer and Other Diseases

CAMK2N2 (CAM-KIIN) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Camk2 family of proteins, which are involved in the regulation of cell growth, differentiation, and survival. The Camk2 family of proteins has been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

CAMK2N2 has been identified as a potential drug target or biomarker for several reasons. Firstly, it is involved in the regulation of cell growth and survival, which are critical processes that are disrupted in many diseases. Secondly, it is expressed in a variety of tissues and organs, which makes it a potential biomarker for various diseases. Lastly, its function in cell survival and growth has been implicated in the development and progression of several diseases, including cancer.

Drug Targets
CAMK2N2 is a protein that can be targeted by small molecules, such as drugs that can inhibit its activity or enhance its sensitivity to certain treatments. There are several potential drug targets for CAMK2N2, including inhibitors of the Camk2 signaling pathway, which is involved in the regulation of cell growth and survival.

One of the most promising potential drug targets for CAMK2N2 is the inhibitor of the Camk2 kinase, which is a protein that is involved in the regulation of cell growth and survival. The Camk2 kinase is a critical enzyme that is involved in the regulation of several cellular processes, including cell growth, differentiation, and survival. Its inhibition has been shown to be effective in treating various diseases, including cancer.

Another potential drug target for CAMK2N2 is the inhibitor of the PI3K/Akt signaling pathway, which is involved in the regulation of cell survival and growth. The PI3K/Akt signaling pathway is a critical pathway that is involved in the regulation of cellular processes, including cell survival, angiogenesis, and inflammation. Its inhibition has been shown to be effective in treating various diseases, including neurodegenerative diseases.

Biomarkers
CAMK2N2 is also a potential biomarker for several diseases, including cancer. Its expression has been shown to be elevated in various types of cancer, including breast cancer, lung cancer, and colorectal cancer. Its levels have also been shown to be elevated in various tissues and organs, including the brain, heart, and kidneys. These findings suggest that CAMK2N2 may be a useful biomarker for the diagnosis and prognosis of cancer.

Functions in Cell Survival and Growth
CAMK2N2 is involved in the regulation of cell growth and survival. It is a critical enzyme that is involved in the regulation of several cellular processes, including cell survival, angiogenesis, and inflammation. Its activity in these processes is dependent on the activity of several other proteins, including the cell survival factor PDGF-BB and the angiogenesis factor VEGF.

In cell survival, CAMK2N2 is involved in the regulation of the survival signaling pathway. This pathway is involved in the regulation of cell survival by promoting the production of PDGF-BB, which is a protein that promotes cell survival. The production of PDGF-BB is dependent on the activity of the Camk2 signaling pathway, which is inhibited by the Ang-1 gene.

In angiogenesis, CAMK2N2 is involved in the regulation of the vascular endothelial cell (VEC) survival and angiogenesis. VEC are responsible for the formation of new blood vessels, which is a critical process in the development of cancer. The production of VEC is dependent on the activity of the PDGF-BB signaling pathway, which is activated by the

Protein Name: Calcium/calmodulin Dependent Protein Kinase II Inhibitor 2

Functions: Potent and specific cellular inhibitor of CaM-kinase II (CAMK2) (PubMed:11444830). Traps Ca(2+)/calmodulin on CAMK2 (By similarity)

The "CAMK2N2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CAMK2N2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets